Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment.
Averbuch I, Tschernichovsky R, Yust-Katz S, Rotem O, Limon D, Kurman N, Icht O, Reinhorn D, Moskovitz M, Hanovich E, Benouaich-Amiel A, Siegal T, Zer A, Gal O. Averbuch I, et al. Among authors: reinhorn d. J Neurooncol. 2024 Feb;166(3):461-469. doi: 10.1007/s11060-024-04562-0. Epub 2024 Feb 7. J Neurooncol. 2024. PMID: 38324192 Free PMC article.
Docetaxel-induced Acute Myositis.
Sulkes A, Reinhorn D, Cohen T, Peysakhovich T, Neiman V, Brenner B. Sulkes A, et al. Among authors: reinhorn d. Isr Med Assoc J. 2023 Jan;25(1):75-76. Isr Med Assoc J. 2023. PMID: 36718745 Free article. No abstract available.
dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50.
Holtzman L, Moskovitz M, Urban D, Nechushtan H, Keren S, Reinhorn D, Wollner M, Daher S, Rottenberg Y, Rovitzky Y, Shochat T, Bar J, Dudnik E. Holtzman L, et al. Among authors: reinhorn d. Clin Lung Cancer. 2022 Mar;23(2):122-134. doi: 10.1016/j.cllc.2021.12.006. Epub 2021 Dec 24. Clin Lung Cancer. 2022. PMID: 35034862
Response to Soran et al.
Reinhorn D, Amir E, Goldvaser H. Reinhorn D, et al. Breast. 2021 Dec;60:306-307. doi: 10.1016/j.breast.2021.10.007. Epub 2021 Oct 19. Breast. 2021. PMID: 34690052 Free PMC article. No abstract available.
Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study.
Reinhorn D, Kuchuk I, Shochat T, Nisenbaum B, Sulkes A, Hendler D, Rotem O, Tsoref D, Olitzky O, Goldvaser H, Sarfaty M, Neiman V, Prus J, Gottfried M, Yust-Katz S, Yerushalmi R. Reinhorn D, et al. Breast Cancer Res Treat. 2021 Jul;188(2):379-387. doi: 10.1007/s10549-021-06198-4. Epub 2021 Mar 27. Breast Cancer Res Treat. 2021. PMID: 33772709
Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors.
Icht O, Darzi N, Shimony S, Jacobi O, Reinhorn D, Landman Y, Mutai R, Averbuch I, Shochat T, Spectre G, Raanani P, Rotem O, Dudnik E, Peled N, Zer A, Leader A. Icht O, et al. Among authors: reinhorn d. J Thromb Haemost. 2021 May;19(5):1250-1258. doi: 10.1111/jth.15272. Epub 2021 Mar 16. J Thromb Haemost. 2021. PMID: 33605020 Free article.
15 results